Establishing the Microcirculatory Effects of Ticagrelor on Tissue Perfusion in Critical Limb Ischemia

NCT02230527 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

46

Enrollment

OTHER

Sponsor class

Stopped Lack of enrollment

Conditions

Peripheral Arterial Disease

Interventions

DRUG: Ticagrelor
DRUG: Clopidogrel

Sponsor

The Cleveland Clinic